美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Sionna Therapeutics

11.07

+1.0710.70%

盘后：11.070.00000.00%16:00 EDT

成交量：18.62万

成交额：204.10万

市值：4.88亿

市盈率：-0.69

高：11.51

开：9.68

低：9.39

收：10.00

数据加载中...

总览公司新闻公告

Sionna Therapeutics, Inc.2024财年实现净利润-61.69百万美元，同比减少30.53%

Sionna Therapeutics第四季度每股收益（EPS）由去年同期的$(3.93)提升至$(3.38)

美国研究综述-Accolade、Crowdstrike、万豪国际集团

Sionna Therapeutics(SION.US)获Stifel首次覆盖，给予买入评级, 目标价32.00美元。

异动解读 | Sionna Therapeutics盘中大涨38.89%,开盘即大涨33%创新高

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SION/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SION","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","market":"US","secType":"STK","nameCN":"Sionna Therapeutics","latestPrice":11.07,"timestamp":1744920000000,"preClose":10,"halted":0,"volume":186207,"hourTrading":{"tag":"盘后","latestPrice":11.07,"preClose":11.07,"latestTime":"16:00 EDT","volume":2081,"amount":23036.67,"timestamp":1744920007145},"delay":0,"floatShares":15943083,"shares":44124394,"eps":-15.986072,"marketStatus":"休市中","change":1.07,"latestTime":"04-17 16:00:00 EDT","open":9.68,"high":11.51,"low":9.39,"amount":2040956.7276,"amplitude":0.212,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.986072,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1738904400000,"exchange":"NASDAQ","adjPreClose":10,"preHourTrading":{"tag":"盘前","latestPrice":9.67,"preClose":10,"latestTime":"07:02 EDT","volume":538,"amount":4936.619674,"timestamp":1744887734606},"postHourTrading":{"tag":"盘后","latestPrice":11.07,"preClose":11.07,"latestTime":"16:00 EDT","volume":2081,"amount":23036.67,"timestamp":1744920007145},"volumeRatio":1.3690140965305357},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","floatShares":15943083,"roa":"-37.10%","roe":"-61.44%","lyrEps":-15.986072,"volumeRatio":1.3690140965305357,"shares":44124394,"dividePrice":0,"high":11.51,"amplitude":0.212,"preClose":10,"low":9.39,"week52Low":7.255,"pbRate":"-2.98","week52High":25.19,"institutionHeld":0,"latestPrice":11.07,"eps":-15.986072,"divideRate":0,"volume":186207,"delay":0,"ttmEps":-15.986072,"open":9.68,"prevYearClose":18,"prevWeekClose":7.87,"prevMonthClose":10.46,"prevQuarterClose":10.46,"fiveDayClose":7.66,"twentyDayClose":13.88,"sixtyDayClose":18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SION\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521237119","title":"Sionna Therapeutics, Inc.2024财年实现净利润-61.69百万美元，同比减少30.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2521237119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521237119?lang=zh_cn&edition=fundamental","pubTime":"2025-03-22 01:00","pubTimestamp":1742576426,"startTime":"0","endTime":"0","summary":"3月22日，Sionna Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-61.69百万美元，同比减少30.53%；其中营业收入为0.00美元，每股基本收益为-1.40美元。从资产负债表来看，Sionna Therapeutics, Inc.总负债19.10百万美元，其中短期债务1.07百万美元，资产负债比为0.10，流动比率为0.15。机构评级：截至2025年3月22日，当前有2家机构对Sionna Therapeutics, Inc.目标价做出预测，其中目标均价为38.50美元，其中最低目标价为32.00美元，最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250322010035a69f2a2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250322010035a69f2a2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SION","LENZ"],"gpt_icon":0},{"id":"1169014587","title":"Sionna Therapeutics第四季度每股收益（EPS）由去年同期的$(3.93)提升至$(3.38)","url":"https://stock-news.laohu8.com/highlight/detail?id=1169014587","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169014587?lang=zh_cn&edition=fundamental","pubTime":"2025-03-20 19:20","pubTimestamp":1742469626,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics（股票代码SION）第四季度每股收益（EPS）为$(3.38)，较去年同期的$(3.93)有所提升。以上内容来自Benzinga Earnings专栏，原文如下：$Sionna Therapeutics(SION)$ Q4 EPS $(3.38) Up From $(3.93) YoY","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Sionna Therapeutics第四季度每股收益（EPS）由去年同期的$(3.93)提升至$(3.38)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"gpt_icon":0},{"id":"2517961069","title":"美国研究综述-Accolade、Crowdstrike、万豪国际集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2517961069","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517961069?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 15:53","pubTimestamp":1741161204,"startTime":"0","endTime":"0","summary":"美国研究综述-Accolade、Crowdstrike、万豪国际集团路透社3月5日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Accolade、Crowdstrike 和万豪国际集团。要闻  * Accolade Inc ACCD.O：Piper Sandler将其评级从 \"增持 \"下调至 \"中性\"。* Crowdstrike CRWD.O：Piper Sandler将目标价从375美元上调至400美元 * 万豪国际集团 MAR.O：摩根士丹利将目标价从289.00美元上调至298.00美元以下是路透社周三报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3T3PO0T1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU0289960550.SGD","LU0240878834.USD","ACHC","BK4596","TGT","BK4124","LU2355687059.USD","LU2362541273.HKD","CRWD","INGM","LU1718418525.SGD","SGRY","AZO","PASG","LU1244550577.SGD","HLT","CHPT","LU2092937221.SGD","ROST","MAR","ACCD","BK4598","LU0965509283.SGD","LU0061475181.USD","H","SION","LU0057025933.USD","BBY","LU2106854487.HKD","CHH","BOX","MGA","LU0965509010.AUD","LU2237443978.SGD","WH","AKYA","LU2125910179.SGD","LU2133065610.SGD","YUM","LU0689626769.HKD","LU1892829315.USD","LU0511384066.AUD","LU2264538146.SGD","WM","WDC","RSG","SNDK","LU2413666426.HKD","LU0942090050.USD"],"gpt_icon":1},{"id":"2517602818","title":"Sionna Therapeutics(SION.US)获Stifel首次覆盖，给予买入评级, 目标价32.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517602818","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517602818?lang=zh_cn&edition=fundamental","pubTime":"2025-03-05 01:42","pubTimestamp":1741110163,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics(SION.US)获Stifel首次覆盖，给予买入评级, 目标价32.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05014248524159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","SION"],"gpt_icon":0},{"id":"1177801026","title":"异动解读 | Sionna Therapeutics盘中大涨38.89%,开盘即大涨33%创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1177801026","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177801026?lang=zh_cn&edition=fundamental","pubTime":"2025-02-08 02:02","pubTimestamp":1738951356,"startTime":"0","endTime":"0","summary":"生物技术公司Sionna Therapeutics今日盘中股价大涨38.89%,引发市场高度关注。\n\n公司今日在纳斯达克交易所成功 IPO,首次公开募股规模扩大至1.91亿美元,发行价为每股18美元。然而当日开盘后,Sionna Therapeutics的股价即飙升至24美元,较发行价飙升33%,充分体现了资本市场对公司的热捧。\n\n作为一家从事治疗囊性纤维化疾病药物研发的生物技术公司,Sionna Therapeutics正在与制药业巨头Vertex公司展开激烈竞争,力图在这一快速增长的市场占据一席之地。分析人士认为,Sionna成功 IPO体现了投资者对其长期前景的高度认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Sionna Therapeutics盘中大涨38.89%,开盘即大涨33%创新高","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SION"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SION\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SION\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SION\",market:\"US\",delay:true,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SION\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"SION","date":"2025-04-17","current":-7.152833,"percent":0.836735,"low":-18.418073,"twenty":-14.648998,"median":-11.146455,"eighty":-7.438946,"high":-5.47907,"avg":-10.891452,"sd":3.207127,"marketCap":441243940},"quantilePoints":[{"date":"2025-02-07","current":-13.261013,"twenty":-12.252025,"median":-10.738543,"eighty":-9.22506,"marketCap":765372600},{"date":"2025-02-14","current":-14.940741,"twenty":-16.115077,"median":-14.940741,"eighty":-13.535074,"marketCap":862319796},{"date":"2025-02-21","current":-15.365065,"twenty":-15.365065,"median":-14.763927,"eighty":-14.631317,"marketCap":886810118},{"date":"2025-02-28","current":-11.280197,"twenty":-15.101402,"median":-14.760244,"eighty":-13.045594,"marketCap":651047865},{"date":"2025-03-07","current":-11.960372,"twenty":-15.059369,"median":-14.631317,"eighty":-11.310767,"marketCap":690304817},{"date":"2025-03-14","current":-13.068521,"twenty":-15.036515,"median":-13.072343,"eighty":-11.387191,"marketCap":754262771},{"date":"2025-03-21","current":-10.607665,"twenty":-14.940741,"median":-12.594692,"eighty":-11.280197,"marketCap":612232003},{"date":"2025-03-28","current":-8.569094,"twenty":-14.763927,"median":-12.189644,"eighty":-10.607665,"marketCap":528610240},{"date":"2025-04-04","current":-8.304439,"twenty":-14.75656,"median":-11.44833,"eighty":-8.654927,"marketCap":512284214},{"date":"2025-04-11","current":-5.47907,"twenty":-14.719724,"median":-11.345158,"eighty":-8.304439,"marketCap":337992858},{"date":"2025-04-17","current":-7.152833,"twenty":-14.648998,"median":-11.146455,"eighty":-7.438946,"marketCap":441243940}],"updateTime":1745129792607}}}